LUMIRADX LTD - *W EXP 09/28/202 (LMDWF)

CUSIP: G5709L117

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / *W EXP 09/28/202
Total 13F shares
6,292,969
Share change
-1,888,227
Total reported value
$344,343
Price per share
$0.01
Number of holders
14
Value change
-$59,759
Number of buys
3
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP G5709L117?
CUSIP G5709L117 identifies LMDWF - LUMIRADX LTD - *W EXP 09/28/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUMIRADX LTD - *W EXP 09/28/202 (LMDWF) as of Q4 2023

As of 31 Dec 2023, LUMIRADX LTD - *W EXP 09/28/202 (LMDWF) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,292,969 shares. The largest 10 holders included CVS HEALTH Corp, GOLDMAN SACHS GROUP INC, LMR Partners LLP, BALYASNY ASSET MANAGEMENT L.P., KIM, LLC, MMCAP International Inc. SPC, Walleye Capital LLC, WOLVERINE ASSET MANAGEMENT LLC, Covalent Partners LLC, and Cresset Asset Management, LLC. This page lists 14 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.